Hi Ad,
That's how I see it as well, I did support selling the canine license for a long time, but when I break it down I no longer think it a good idea. Imagine where a constituent goes to their local member and complains that the very expensive MND treatment [Around $150,000 per annum] is available as a canine treatment for less the $10,000. What a grandstanding opportunity this would create. It could seriously complicate matters.
Cheers
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-432
-
- There are more pages in this discussion • 547 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.020(10.3%) |
Mkt cap ! $85.08M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 17.5¢ | $245.7K | 1.349M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 347692 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 35481 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |